London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
June 10, 2024 14:33 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Presents Advancement of LRP-661, Their Lead Drug Candidate, at the New Antiepileptic Drug Conference in Madrid, Spain
South Meadows Recovery Successfully Renews Joint Commission Accreditation, Affirming Its Commitment to High-Quality Addiction Treatment in Austin
June 10, 2024 09:00 ET
|
South Meadows Recovery
Austin, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- South Meadows Recovery, a prominent leader in Austin drug rehab, is delighted to announce the successful renewal of The Joint Commission’s Gold...
Sidetrade launches powerful Order-to-Cash Generative AI features
June 10, 2024 08:30 ET
|
Sidetrade
First generative AI (GenAI) features now available within the Sidetrade platformGame-changing innovation for finance teams: Sidetrade’s GenAI merges powerful LLM algorithms with the industry’s only...
Sidetrade lance des fonctionnalités d'IA générative dédiées à l’Order-to-Cash
June 10, 2024 08:30 ET
|
Sidetrade
Premières fonctionnalités d’IA générative (Gen AI) disponibles sur la plateforme SidetradeInnovation majeure pour les équipes financières : La GenAI de Sidetrade combine de puissants algorithmes LLM...
Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
June 10, 2024 08:00 ET
|
Clinical Ink
Winston Salem, NC, June 10, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, announced the appointment of Dr. Nicholas Alp as Chief Medical Officer and EVP, Medical...
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 10, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 – – Phase 1b study portion of multiple...
Mikra Completes Design of New Product and Advances Shipment Date
June 10, 2024 07:00 ET
|
Lifeist Wellness Inc.
Mikra completes design of new product that delivers superior clarity of cognition and improved memory in collaboration with Jose Bautista and advances shipment date FOCUS combines a precision blend...
Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly
June 07, 2024 20:18 ET
|
Qu Biologics, Inc.
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce that the RESILIENCE Study, a clinical trial...
The Portnoy Law Firm Announces Investigation of AdaptHealth Corp. (NASDAQ: AHCO)
June 07, 2024 15:23 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm is investigating potential claims...
Raydiant Survey Reveals AI's Transformative Impact on the Restaurant Industry
June 07, 2024 13:45 ET
|
Raydiant
SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Raydiant, the leading in-location Experience OS, today released its inaugural "The State of AI in Restaurants" report. The study, based on a survey...